Healthcare & Lifesciences
Healthcare & Lifesciences is experiencing a significant transformational shift driven by evolving customer preferences and technological advancements. Established businesses are closing while disruptive newcomers are emerging. Consumers are looking for more convenient, tailored, and affordable healthcare services, with technology enabling the delivery of such services. Telehealth, wearables, a wide range of new care delivery entrants, and AI-powered diagnostic tools are making healthcare more accessible and efficient. The adoption of electronic health records and data analytics is also enhancing patient outcomes and care coordination. Technological breakthroughs are facilitating precision medicine, genomics, and gene therapies that provide tailored treatments for diverse illnesses.
Frost & Sullivan is proud to be partnering with leading trade associations and best-in-class event organizers.
Precision Health
Precision health is increasingly essential as value-based care and population health management require tailored and precise care delivery that caters to patients’ expectation for personalized care. Failure to adopt precision-based approaches can lead to lack of differentiation, increased costs, and inadequate patient outcomes.
Healthcare IT
Healthcare Information Technology is taking a larger role in the drive toward better patient outcomes. Health IT can assist healthcare organizations to address rising costs, workforce shortages, shifting payment models, data interoperability, increasing automation, insights that improve outcomes and health equity initiatives.
Chronic Care
Chronic conditions are becoming more prevalent and complex, requiring ongoing and coordinated care. Improving chronic care management is a requirement to improve the health of people in both developed and developing countries and to reduce health system costs in every country for better patient outcomes and population health management.
Women's Health
It is increasingly important to focus on women’s health because of the growing recognition of women’s unique healthcare needs. With the emergence of the sheconomy, it is essential to prioritize women’s health to promote gender equity and improve overall health outcomes for women globally.
Latest Healthcare Growth Opportunity News
Transforming Chronic Care: Prioritizing Patient-Centered Models for Enhanced Outcomes
Patient-centered care, as defined by the National Quality Forum, emphasizes collaborative partnerships among patients, their families, and healthcare providers. It prioritizes individuals' priorities, goals, needs, and values for better health outcomes. Despite...
Growth Perspectives: Key Highlights from HIMSS 2024 Summit in Orlando
Frost & Sullivan’s experts had the privilege of covering the latest developments at the HIMSS Global Health Conference & Exhibition 2024 in Orlando. If you missed attending this event, here are some of the key points and observations from the 5-day conference:...
Growth Perspectives: Key Highlights from DCAT 2024
The Drug, Chemical & Associated Technologies Association (DCAT) 2024 event held in New York City on March 18-21 showcased product and technology innovations and capabilities presentations by member companies. Industry participants highlighted capability expansion,...
Are YOU ready to embrace transformation?
Frost & Sullivan has six decades of experience analysing industry transformation and identifying innovative growth opportunities. Start your transformational journey that, fuelled by four powerful components, will ensure your success in navigating the ever-changing landscape of your industry.
Schedule a Growth Dialog with our team to dive deeper into transformational strategies and explore specific needs within your company.
Become a Frost Growth Expert in your area of specialization and share your expertise and passion with the community through our think tanks.
Join Frost & Sullivan’s Growth Council and gain access to leading global executives and think tanks focused on the transformational growth strategies of your industry.
Designate your company for evaluation as a Company to Action to increase exposure to investors, partnership potential, new M&A opportunities, and other growth prospects for your business.